“…We found that soma translocation of interneuron progenitors was dramatically decreased with 50 μM blebbistatin treatment (10.55 ± 2.25%, n=2 hfMCOs, 63 cells in total, mean ± SD) compared with control hfMCOs (41.23 ± 3.20%, n=4 hfMCOs, 79 cells in total, mean ± SD) within 10 hours, and 100 μM blebbistatin treatment completely abolished migration (n=2 hfMCOs, 44 cells in total, mean ± SD) (Figure 7H and 7I; Movie S5 and S6). The average migrating speed of interneuron progenitors was 0.19 ± 0.01 μm/min (n=35 cells from 4 hfMCOs, mean ± SD) (Figure 7J), which was close to the speed observed from living embryo but slower than that obtained from MGE explant culture (Bellion et al, 2005; Yanagida et al, 2012), indicating that the cellular environment of hfMCOs might closely approximate their in vivo counterparts. With myosin II inhibition, the migration speed largely decreased (Figure 7J).…”